BioTime (BTX) Misses Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts BTX Hot Sheet
Join SI Premium – FREE
BioTime (NYSE: BTX) reported Q1 EPS of ($0.19), $0.05 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $1.43 million.
For earnings history and earnings-related data on BioTime (BTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
- Byline Bancorp (BY) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
